Press release
Targeted Therapy Market Intelligence Report Covers Trends, Segments And Regional Growth
Targeted Therapy Market
Projected Market Size and Growth Path of the Targeted Therapy Market
The targeted therapy market is anticipated to reach a substantial $158.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6%. This expansion is largely fueled by increased investments in personalized medicine, the rising integration of AI in drug discovery, wider adoption of precision diagnostics, growing preference for therapies with fewer toxic side effects, and heightened clinical trial activities focusing on oncology. Key developments expected during this period include the formulation of more precise oncology medications, expanded use of biomarker-driven treatment selections, combination targeted therapies, companion diagnostic tools, and the design of drugs tailored specifically to tumor types.
The targeted therapy market size has grown strongly in recent years. It will grow from $109.99 billion in 2025 to $118.16 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing global cancer incidence, expansion of oncology research funding, growing adoption of monoclonal antibodies, advancements in molecular biology research, rising approval of targeted cancer drugs.
Download a free sample of the targeted therapy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Players Shaping the Targeted Therapy Industry
The targeted therapy landscape is dominated by several influential companies that continue to drive innovation and market growth. These key players include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., and Daiichi Sankyo Company Limited.
Notable Acquisition Enhances Johnson & Johnson's Portfolio
In November 2025, Johnson & Johnson made a significant move by acquiring Halda Therapeutics for $3.05 billion. This acquisition is aimed at boosting Johnson & Johnson's biopharmaceutical pipeline, enhancing its capabilities in protein and peptide engineering, broadening its portfolio of innovative therapies, and accelerating the advancement of next-generation biologics. Halda Therapeutics, a US-based biotech firm, specializes in designing and developing site-specific protein and peptide therapeutics, aligning perfectly with Johnson & Johnson's strategic goals.
View the full targeted therapy market report:
https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Strategic Collaborations Driving Innovation in Targeted Therapy
Leading companies in the targeted therapy space are increasingly turning to strategic partnerships to strengthen their service offerings and foster innovation. Strategic alliances enable organizations to collaborate effectively toward common objectives, enhancing their capacity to deliver cutting-edge therapies. For example, in September 2023, Shine Technologies, a US pharmaceutical firm specializing in radioactive isotopes for medical applications, partnered with Curadh MTR Inc., a company focused on accelerating molecularly targeted radiation therapies for solid tumors. This collaboration is designed to leverage the precision of radioisotopes to target cancer cells more efficiently, potentially transforming outcomes for patients and advancing cancer treatment modalities.
Detailed Segmentation of the Global Targeted Therapy Market
This report divides the targeted therapy market into distinct segments to provide a comprehensive overview:
1) By Type:
- Small Molecule Medicines
- Monoclonal Antibodies
2) By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
3) By Application:
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Renal Cancer
- Other Applications
Further subcategories include:
- Small Molecule Medicines such as Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, and other small molecule therapies
- Monoclonal Antibodies including Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, and other monoclonal antibodies
This segmentation highlights the diversity of therapeutic options and distribution strategies currently shaping the targeted therapy market's landscape.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Targeted Therapy Market Intelligence Report Covers Trends, Segments And Regional Growth here
News-ID: 4615119 • Views: …
More Releases from The Business Research Company
Triple Negative Breast Cancer Market Demonstrates Long-Term Growth Potential At …
An in-depth look into the triple negative breast cancer market reveals promising growth and significant advancements in treatment options. As research intensifies and new therapies emerge, this sector is poised for notable expansion and increased innovation in the coming years.
Projected Market Growth of the Triple Negative Breast Cancer Market by 2030
The market for triple negative breast cancer is anticipated to experience substantial growth, reaching a valuation of $1.48…
Treatment-Resistant Depression Market Outlook Signals Expansion To $2.59 Billion …
The treatment-resistant depression market is on track for significant expansion as new therapies and technologies emerge to address persistent challenges in managing this complex condition. With ongoing advancements in personalized medicine and digital health, this sector is expected to evolve rapidly in the coming years. Here's an in-depth look at the market size, key players, influential trends, and detailed segmentation shaping the industry's outlook.
Forecast of the Treatment-Resistant Depression Market Size…
Traumatic Brain Injuries Assessment Market Report 2026 Market Outlook Supported …
The assessment of traumatic brain injuries (TBI) is a rapidly evolving field, driven by technological advancements and a growing need for precise and timely diagnosis. As healthcare providers seek more effective tools to evaluate brain trauma, the market for TBI assessment is poised for notable expansion. Below is an in-depth look at how this market is expected to develop, the leading players involved, and the trends shaping its future.
Traumatic Brain…
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Insights Highlig …
The treatment landscape for transthyretin amyloid cardiomyopathy (ATTR-CM) is on the brink of remarkable growth, driven by innovative medical approaches and increased focus on rare diseases. As advancements continue to emerge, this market is set to transform significantly by 2030, offering new hope for patients affected by this challenging cardiac condition.
Projected Market Growth of the ATTR-CM Treatment Market
The transthyretin amyloid cardiomyopathy treatment market is anticipated to expand dramatically,…
More Releases for Johnson
Tendonitis Treatment Market Future Prospects | • Johnson & Johnson • Pfizer
Worldwide Market Reports has added a new research study on "Tendonitis Treatment Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends,…
Sarcoma Treatment Market Is Booming Worldwide 2025-2032 | Amgen Inc., Johnson & …
Coherent Market Insights has released a statistical report titled "Sarcoma Treatment Market Recent Trends, In-depth Analysis, Size, and Forecast 2025-2032." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the…
Siltuximab Market Analysis By Top Keyplayers - Johnson & Johnson
The "Siltuximab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Siltuximab Market, 2024-2031
Verified Market Research's most recent report, "Siltuximab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Artificial Limbs and Joints Market Expected to reach a Hugh Growth by 2031 | Art …
Artificial Limbs and Joints Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report…
Artificial Limbs and Joints Industry to Witness Massive Growth (2024-2031) | Art …
Artificial Limbs and Joints Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Artificial Limbs and Joints market emerge as the sector's next great thing? To discover the answer, look at the Artificial Limbs and…
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive…
